US group acquires Danish medtech company - aims to triple production in a year

Danish medtech company Ellipse becomes part of a US group. The company now expects to triple the production capacity. "They really know how to churn out products from their sales channels," says CEO Jacob Kildegaard Larsen.

Photo: Ellipse/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Nye Darzalex-data skal fremlægges på hæmatologikonference

Janssen og Genmab har fået lov til at fremlægge data fra et studie med Darzalex i nydiagnosticerede patienter på den store hæmatologikonference ASH til december. Der er allerede løftet lidt af sløret for de yderst positive data, og aktien steg med omtrent 7 pct. på nyheden.

Related articles